Approval · Notice of Compliance 1622 · 1999
PROREG: Notice of Compliance 1622
Issued October 7, 1999
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1622
- Date
- October 7, 1999
- Company
- Smithkline Beecham Pharma, Division Of Smithkline Beecham Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Congestive heart failure agent
Products in this notice
Medicinal ingredients
- CARVEDILOL 3.125 MG per TAB
- CARVEDILOL 6.25 MG per TAB
- CARVEDILOL 12.5 MG per TAB
- CARVEDILOL 25 MG per TAB